Advances in diabetes research facilitated by QIAseq UPX 3′
Chronic exposure to environmental arsenic is associated with several diseases, including diabetes mellitus. Join our live webinar, where we discuss how QIAseq UPX 3’ Transcriptome technology for 3’ RNA-seq, as part of QIAGEN Genomic Services, played an integral role in uncovering the connection between arsenic and the development of type II diabetes. Discover how this technology enables economies of scale, increases the ability to generate large, focused data sets affordably and lowers the cost of sequencing. The webinar will be followed by a live Q&A session with our experts. Join us to discover how 3’ RNA-seq can accelerate a deeper understanding of various diseases and pathways.
- Title: Investigating the Nrf2 transcriptome as a driver of arsenic-promoted type II diabetes
- Date: Thursday, May 14, 2020
- Time: 11:00 a.m. and 2:00 p.m. EST
- Speakers: Matthew Dodson, Ph.D., Post-doctoral Research Associate, Dept. of Pharmacology and Toxicology, University of Arizona, and Raphael Werding, M.Sc., Senior Global Product Manager, Genomic Services, QIAGEN